CareMax Reports Second Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance
August 9, 2023 6:57 AM EDTCareMax (NASDAQ: CMAX) reported Q2 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $224.4 million versus the consensus estimate of $184.41 million.
GUIDANCE:
CareMax sees FY2023 revenue of $750-800 million, versus the consensus of $740... More
